FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 100,742,490
- Share change
- -14,400,517
- Total reported value
- $166,216,764
- Put/Call ratio
- 38%
- Price per share
- $1.65
- Number of holders
- 154
- Value change
- -$49,322,737
- Number of buys
- 69
- Number of sells
- 87
Quarterly Holders Quick Answers
What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31189P102:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
|
Company |
11%
|
13,169,057
|
$46,091,700 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
8.6%
|
10,473,250
|
$36,656,378 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.5%
|
10,404,123
|
$36,414,431 | — | 30 Sep 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
4.6%
|
5,572,607
|
$19,504,125 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.3%
|
5,252,974
|
$18,385,409 | — | 30 Sep 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
4.1%
|
4,960,910
|
$17,363,185 | — | 30 Sep 2024 | |
| Bellevue Group AG |
13F
|
Company |
4%
|
4,839,779
|
$16,939,227 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.5%
|
4,282,077
|
$14,987,270 | — | 30 Sep 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.9%
|
3,555,871
|
$12,445,549 | — | 30 Sep 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
2.8%
|
3,379,064
|
$11,826,724 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.8%
|
3,377,650
|
$11,821,776 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
2.5%
|
3,065,747
|
$10,730,115 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.5%
|
3,063,421
|
$10,721,975 | — | 30 Sep 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.5%
|
2,997,772
|
$10,492,202 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.3%
|
2,823,403
|
$9,881,911 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.1%
|
2,619,017
|
$9,167,040 | — | 30 Sep 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2%
|
2,434,198
|
$8,519,693 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
2,258,246
|
$7,905,096 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.5%
|
1,837,304
|
$6,430,565 | — | 30 Sep 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.4%
|
1,685,000
|
$5,897,500 | — | 30 Sep 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.4%
|
1,680,580
|
$5,882,030 | — | 30 Sep 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.3%
|
1,602,120
|
$5,607,000 | — | 30 Sep 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.3%
|
1,587,900
|
$5,557,650 | — | 30 Sep 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
1.2%
|
1,466,934
|
$5,134,269 | — | 30 Sep 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.8%
|
975,000
|
$3,412,500 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.76%
|
927,240
|
$3,245,340 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.71%
|
870,000
|
$3,045,000 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.7%
|
854,195
|
$2,989,682 | — | 30 Sep 2024 | |
| J. Scott Wolchko |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
871,248
mixed-class rows
|
$2,987,354 | — | 01 Feb 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.67%
|
815,160
|
$2,853,062 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.62%
|
763,808
|
$2,673,328 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.57%
|
700,000
|
$2,450,000 | — | 30 Sep 2024 | |
| Edward J. Dulac III |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
526,479
mixed-class rows
|
$1,948,742 | — | 04 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.45%
|
553,100
|
$1,935,851 | — | 30 Sep 2024 | |
| GCM Grosvenor Holdings, LLC |
13F
|
Company |
0.41%
|
495,916
|
$1,735,706 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.38%
|
459,565
|
$1,608,478 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.35%
|
424,277
|
$1,484,972 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.33%
|
404,279
|
$1,414,977 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.3%
|
362,619
|
$1,269,167 | — | 30 Sep 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.29%
|
356,601
|
$1,248,104 | — | 30 Sep 2024 | |
| E Fund Management Co., Ltd. |
13F
|
Company |
0.29%
|
353,771
|
$1,238,198 | — | 30 Sep 2024 | |
| Bruce & Co., Inc. |
13F
|
Company |
0.29%
|
350,000
|
$1,225,000 | — | 30 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.28%
|
345,575
|
$1,209,513 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.26%
|
317,271
|
$1,110,449 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.24%
|
299,286
|
$1,047,502 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.22%
|
270,616
|
$947,156 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.2%
|
249,742
|
$874,097 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0.19%
|
227,981
|
$797,932 | — | 30 Sep 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.18%
|
214,425
|
$750,488 | — | 30 Sep 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.17%
|
209,144
|
$732,000 | — | 30 Sep 2024 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q4 2024
As of 31 Dec 2024,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
154 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
100,742,490 shares.
The largest 10 holders included
Redmile Group, LLC, BlackRock, Inc., VANGUARD GROUP INC, Bellevue Group AG, CITADEL ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), JOHNSON & JOHNSON, BAKER BROS. ADVISORS LP, EcoR1 Capital, LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
156
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
157
Q4 2024 holders
154
Holder diff
-3
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.